Published in Biotech Business Week, January 26th, 2004
According to a study in the January 14, 2004, issue of the Journal of the American Medical Association (JAMA), evidence-based selective referral strategies are being used by an increasing number of insurers to ensure that medical care is provided by high-quality providers and to make sure that patients with high-risk conditions are treated in hospitals with the best outcomes. In the absence of direct-quality measures based on patient outcomes, the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.